Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Math Biosci Eng ; 16(6): 8217-8242, 2019 09 16.
Artigo em Inglês | MEDLINE | ID: mdl-31698665

RESUMO

In this paper we have adapted a delayed dengue model to Zika. By assuming that the epidemic starts by a single infected individual entering a disease-free population at some initial time t0 we have used the least squares parameter estimation technique in R to estimate the initial time t0 using observed Zika data from Brazil as well as the transmission probabilities of Zika in Brazil between humans and mosquitoes and vice-versa. Different values of Aedes aegypti (A. aegypti) biting rate are used throughout the paper. We have estimated the value of the basic reproduction number for Zika in Brazil and calculated the expected number of cases of microcephaly in newborns as a result of women infected with Zika during pregnancy. We started off with a non-age-structured model then introduced age-structure into the model. However in reality seasonality, in particular temperature and rainfall, have a great impact on the population size of A. aegypti. Hence we repeat both the non-age-structured and age-structured analyses introducing seasonality into the A. aegypti birth function to model the effect of these environmental factors.


Assuntos
Microcefalia/epidemiologia , Microcefalia/virologia , Complicações Infecciosas na Gravidez/epidemiologia , Complicações Infecciosas na Gravidez/virologia , Infecção por Zika virus/epidemiologia , Infecção por Zika virus/transmissão , Aedes , Algoritmos , Animais , Brasil/epidemiologia , Controle de Doenças Transmissíveis , Dengue/epidemiologia , Meio Ambiente , Epidemias , Feminino , Humanos , Recém-Nascido , Análise dos Mínimos Quadrados , Modelos Teóricos , Gravidez , Zika virus
2.
Cardiovasc Toxicol ; 19(5): 451-464, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31037602

RESUMO

Carbon monoxide (CO) presents anti-inflammatory and antioxidant activities as a new gaseous neuromessenger produced by heme oxygenase-1 (HO-1) in the body. High salt-induced hypertension is relevant to the levels of pro-inflammatory cytokines (PICs) and oxidative stress in the hypothalamic paraventricular nucleus (PVN). We explored whether CO in PVN can attenuate high salt-induced hypertension by regulating PICs or oxidative stress. Male Dahl Salt-Sensitive rats were fed high-salt (8% NaCl) or normal-salt (0.3% NaCl) diet for 4 weeks. CORM-2, ZnPP IX, or vehicle was microinjected into bilateral PVN for 6 weeks. High-salt diet increased the levels of MAP, plasma norepinephrine (NE), reactive oxygen species (ROS), and the expressions of COX2, IL-1ß, IL-6, NOX2, and NOX4 significantly in PVN (p < 0.05), but decreased the expressions of HO-1 and Cu/Zn-SOD in PVN (p < 0.05). Salt increased sympathetic activity as measured by circulating norepinephrine, and increased the ratio of basal RSNA to max RSNA, in part by decreasing max RSNA. PVN microinjection of CORM-2 decreased the levels of MAP, NE, RSNA, ROS and the expressions of COX2, IL-1ß, IL-6, NOX2, NOX4 significantly in PVN of hypertensive rat (p < 0.05), but increased the expressions of HO-1 and Cu/Zn-SOD significantly (p < 0.05), which were all opposite to the effects of ZnPP IX microinjected in PVN (p < 0.05). We concluded that exogenous or endogenous CO attenuates high salt-induced hypertension by regulating PICs and oxidative stress in PVN.


Assuntos
Anti-Inflamatórios/farmacologia , Anti-Hipertensivos/farmacologia , Antioxidantes/farmacologia , Pressão Arterial/efeitos dos fármacos , Monóxido de Carbono/farmacologia , Citocinas/metabolismo , Hipertensão/prevenção & controle , Mediadores da Inflamação/metabolismo , Compostos Organometálicos/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Núcleo Hipotalâmico Paraventricular/efeitos dos fármacos , Animais , Anti-Inflamatórios/metabolismo , Anti-Hipertensivos/metabolismo , Antioxidantes/metabolismo , Monóxido de Carbono/metabolismo , Ciclo-Oxigenase 2/metabolismo , Modelos Animais de Doenças , Heme Oxigenase (Desciclizante)/metabolismo , Hipertensão/metabolismo , Hipertensão/fisiopatologia , Masculino , Compostos Organometálicos/metabolismo , Núcleo Hipotalâmico Paraventricular/metabolismo , Núcleo Hipotalâmico Paraventricular/fisiopatologia , Ratos Endogâmicos Dahl , Cloreto de Sódio na Dieta
3.
Medicine (Baltimore) ; 98(5): e14382, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30702632

RESUMO

BACKGROUND: Previous studies have reported that spore powder of Ganoderma lucidum (SPGL) may be effective for the treatment of Alzheimer's disease (AD). However, its efficacy is still inconclusive. Thus, this systematic review will aim to assess its efficacy and safety for AD. METHODS: We will search the electronic databases of Cochrane Central Register of Controlled Trials, EMBASE, MEDILINE, the Cumulative Index to Nursing and Allied Health Literature, Allied and Complementary Medicine Database, and Chinese Biomedical Literature Database to assess the efficacy and safety of SPGL for patients with AD from their inceptions to the present. All case-control studies and randomized controlled trials will be considered for inclusion in this study. Two review authors will independently perform the study selection, data extraction, and risk of bias evaluation. RESULTS: The primary outcome includes the cognitive status for patients. The secondary outcomes consist of the quality of life, AD symptoms, and adverse events. CONCLUSIONS: This systematic review will present the existing evidence for the efficacy and safety of SPGL for treating patients with AD. DISSEMINATION AND ETHICS: The results of this systematic review will be disseminated by through peer-reviewed journals. It does not needs ethic approval, because it does not involve individual patient data. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42019119426.


Assuntos
Doença de Alzheimer/terapia , Reishi , Esporos Fúngicos , Humanos , Pós
4.
Toxicol Lett ; 270: 62-71, 2017 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-28185984

RESUMO

Hydrogen sulfide (H2S) is an important gaseous signaling molecule in neuro-modulation, anti-inflammatory, anti-oxidant and anti-hypertensive effects. The paraventricular nucleus (PVN) is a major integrative nucleus in regulating BP and SNA. The aim of this study is to explore whether endogenous or exogenous H2S changed by hydroxylamine hydrochloride (HA) or GYY4137 infused in the PVN affects RSNA and MAP by regulating oxidative stress or the balance between pro-inflammatory cytokines (PICs) and anti-inflammatory cytokines in high salt-induced hypertensive rats. Male Dahl rats were fed by high-salt or normal-salt diet. At the end of the 4th week, GYY4137, HA or vehicle was microinjected into bilateral PVN for 6 weeks. The levels of MAP, HR, plasma norepinephrine (NE), reactive oxygen species (ROS), NOX2, NOX4 and IL-1ß were increased significantly in high salt-induced hypertensive rats. Higher levels of these parameters were detected in the group treated by HA, but lower levels in the GYY4137 group. The trends of H2S, CBS, IL-10 and Cu/Zn SOD were opposite to the parameters described above. These findings suggest that endogenous or exogenous H2S in the PVN attenuates sympathetic activity and hypertensive response, which are partly due to decrease of ROS and PICs within the PVN in high salt-induced hypertension.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Sulfeto de Hidrogênio/farmacologia , Hipertensão/sangue , Estresse Oxidativo/efeitos dos fármacos , Núcleo Hipotalâmico Paraventricular/efeitos dos fármacos , Cloreto de Sódio na Dieta/efeitos adversos , Animais , Anti-Inflamatórios/farmacologia , Cistationina beta-Sintase/antagonistas & inibidores , Cistationina beta-Sintase/genética , Cistationina beta-Sintase/metabolismo , Regulação para Baixo , Frequência Cardíaca/efeitos dos fármacos , Hidroxilamina/farmacologia , Hipertensão/induzido quimicamente , Hipertensão/tratamento farmacológico , Interleucina-10/genética , Interleucina-10/metabolismo , Interleucina-1beta/genética , Interleucina-1beta/metabolismo , Masculino , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Morfolinas/farmacologia , NADPH Oxidase 2 , NADPH Oxidase 4 , NADPH Oxidases/genética , NADPH Oxidases/metabolismo , Norepinefrina/sangue , Compostos Organotiofosforados/farmacologia , Núcleo Hipotalâmico Paraventricular/metabolismo , Ratos , Ratos Endogâmicos Dahl , Espécies Reativas de Oxigênio/metabolismo , Cloreto de Sódio na Dieta/administração & dosagem , Cloreto de Sódio na Dieta/sangue , Superóxido Dismutase/sangue
5.
PLoS One ; 9(7): e102161, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25010576

RESUMO

PURPOSE: To investigate the mechanism of the anti-epileptic effect of Ganoderma lucidum polysaccharides (GLP), the changes of intracellular calcium and CaMK II α expression in a model of epileptic neurons were investigated. METHOD: Primary hippocampal neurons were divided into: 1) Control group, neurons were cultured with Neurobasal medium, for 3 hours; 2) Model group I: neurons were incubated with Mg(2+) free medium for 3 hours; 3) Model group II: neurons were incubated with Mg(2+) free medium for 3 hours then cultured with the normal medium for a further 3 hours; 4) GLP group I: neurons were incubated with Mg(2+) free medium containing GLP (0.375 mg/ml) for 3 hours; 5) GLP group II: neurons were incubated with Mg(2+) free medium for 3 hours then cultured with a normal culture medium containing GLP for a further 3 hours. The CaMK II α protein expression was assessed by Western-blot. Ca(2+) turnover in neurons was assessed using Fluo-3/AM which was added into the replacement medium and Ca(2+) turnover was observed under a laser scanning confocal microscope. RESULTS: The CaMK II α expression in the model groups was less than in the control groups, however, in the GLP groups, it was higher than that observed in the model group. Ca(2+) fluorescence intensity in GLP group I was significantly lower than that in model group I after 30 seconds, while in GLP group II, it was reduced significantly compared to model group II after 5 minutes. CONCLUSION: GLP may inhibit calcium overload and promote CaMK II α expression to protect epileptic neurons.


Assuntos
Anticonvulsivantes/uso terapêutico , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/metabolismo , Cálcio/metabolismo , Epilepsia/tratamento farmacológico , Hipocampo/patologia , Neurônios/enzimologia , Polissacarídeos/uso terapêutico , Reishi/química , Animais , Animais Recém-Nascidos , Anticonvulsivantes/farmacologia , Modelos Animais de Doenças , Epilepsia/enzimologia , Epilepsia/patologia , Fluorescência , Espaço Intracelular/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/patologia , Fitoterapia , Polissacarídeos/farmacologia , Ratos Wistar
6.
PLoS One ; 8(4): e61687, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23637882

RESUMO

Epilepsy can cause cerebral transient dysfunctions. Ganoderma lucidum spores (GLS), a traditional Chinese medicinal herb, has shown some antiepileptic effects in our previous studies. This was the first study of the effects of GLS on cultured primary hippocampal neurons, treated with Mg(2+) free medium. This in vitro model of epileptiform discharge hippocampal neurons allowed us to investigate the anti-epileptic effects and mechanism of GLS activity. Primary hippocampal neurons from <1 day old rats were cultured and their morphologies observed under fluorescence microscope. Neurons were confirmed by immunofluorescent staining of neuron specific enolase (NSE). Sterile method for GLS generation was investigated and serial dilutions of GLS were used to test the maximum non-toxic concentration of GLS on hippocampal neurons. The optimized concentration of GLS of 0.122 mg/ml was identified and used for subsequent analysis. Using the in vitro model, hippocampal neurons were divided into 4 groups for subsequent treatment i) control, ii) model (incubated with Mg(2+) free medium for 3 hours), iii) GLS group I (incubated with Mg(2+) free medium containing GLS for 3 hours and replaced with normal medium and incubated for 6 hours) and iv) GLS group II (neurons incubated with Mg(2+) free medium for 3 hours then replaced with a normal medium containing GLS for 6 hours). Neurotrophin-4 and N-Cadherin protein expression were detected using Western blot. The results showed that the number of normal hippocampal neurons increased and the morphologies of hippocampal neurons were well preserved after GLS treatment. Furthermore, the expression of neurotrophin-4 was significantly increased while the expression of N-Cadherin was decreased in the GLS treated group compared with the model group. This data indicates that GLS may protect hippocampal neurons by promoting neurotrophin-4 expression and inhibiting N-Cadherin expression.


Assuntos
Caderinas/metabolismo , Medicamentos de Ervas Chinesas/farmacologia , Epilepsia/metabolismo , Hipocampo/metabolismo , Fatores de Crescimento Neural/metabolismo , Neurônios/metabolismo , Reishi/química , Animais , Caderinas/genética , Modelos Animais de Doenças , Epilepsia/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Fatores de Crescimento Neural/genética , Neurônios/efeitos dos fármacos , Ratos , Esporos Fúngicos/química
7.
Zhonghua Nan Ke Xue ; 14(9): 792-5, 2008 Sep.
Artigo em Chinês | MEDLINE | ID: mdl-18998461

RESUMO

OBJECTIVE: To investigate the changes of xanthine oxidase (XOD), myeloperoxidase (MPO) and mitochondrial succinate dehydrogenase (SDH) in the testis and the protective effect of ganoderma lucidum spores on the testicular tissue of rats with non-insu- lin-dependent diabetes mellitus (NIDDM). METHODS: Fifty male Wistar rats were divided randomly into a model, a ganoderma and a normal control group, the first two groups injected with 2% STZ (25 mg/kg) through the peritoneum, and the last one with half-and-half sodium citrate/citrate buffer solution. Two weeks after normal diet, glucose tolerance tests were performed and the rats with abnormal glucose tolerance in the model and ganoderma groups received high-fat and high-carbohydrate food, the latter given ganoderma lycium spores (250 mg/kg x d) in addition, both for 10 weeks and all rats fed alone. Glucose tolerance tests were repeated 1 day before the end of the experiment and the testes of the rats were harvested for the determination of XOD, MPO and SDH. RESULTS: SDH was significantly lower (P < 0.05) while XOD and MPO significantly higher in the model group than in the ganoderma and control groups (P < 0.05). The model rats exhibited abnormal convoluted seminiferous tubules, indistinct parietal layers, decreased or abolished gonepoiesis, luminal peripheral fibrous tissue (interstitial substance) accrementition, basal lamina thickening, and vessel wall fibrous tissue accrementition and sclerosis. CONCLUSION: Ganoderma lucidum spores can protect the testis of diabetic rats by reducing free radical-induced damage to the testicular tissue and enhancing the activity of SDH.


Assuntos
Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Medicamentos de Ervas Chinesas/uso terapêutico , Reishi , Testículo/metabolismo , Animais , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Masculino , Peroxidase/metabolismo , Ratos , Ratos Wistar , Esporos Fúngicos , Succinato Desidrogenase/metabolismo , Xantina Oxidase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...